Dosage and Administration Saxenda is administered via subcutaneous injection, typically once a day. The dosage may vary depending on individual health factors and the desired weight loss goals.

The U.S. Food and Drug Administration today approved Saxenda (liraglutide [rDNA origin] injection) as a treatment option for chronic weight management in addition to a reduced-calorie diet and ...

Saxenda (liraglutide) is a drug currently prescribed for the treatment of type 2 diabetes. A new study has demonstrated that the drug may well be useful in helping people lose weight, even if they are ...

Teva Pharmaceuticals has launched the first generic GLP-1 drug for weight loss in adults and adolescents; a lower-cost ...

By comparison, Saxenda (liraglutide) prompted similar weight loss in only 29% of those being treated for obesity and 12% being treated for type 2 diabetes.

Teva Pharmaceuticals gained FDA approval to launch the first generic GLP-1 drug for weight loss, a liraglutide injection based on Saxenda.

The weight-loss drug liraglutide (Saxenda) helped obese children lower their BMI and reach a healthier weight, researchers report.

If added, liraglutide will be the first weight-loss medication to make the Essential Medicines List, making way for other weight-loss drugs like newer and more potent drug Wegovy.

Ozempic and its weight-loss cousin, Wegovy, outperform an earlier drug targeting the same gut hormone, a new study shows Ozempic produced 10% or more weight loss in 61% of obese people compared ...